Science policy implications to DNA recombinant molecule researchU.S. Government Printing Office, 1977 - 1293 pages |
Contents
Technology Cambridge Mass | 133 |
Dr Ethan Signer professor of biology Massachusetts Institute | 139 |
Dr David Baltimore American Cancer Society research professor | 158 |
1 other sections not shown
Common terms and phrases
activities agencies amendment American analysis antibiotic resistance antibiotics anticodon Association bacteria bacterium basic benefits biohazards biological containment cancer cells Chairman THORNTON chemical citizen coli Committee concern conduct Congress decision discussion disease DNA recombinant drug environment environmental example experiments facilities Federal Fort Detrick Fredrickson freedom genes genetic engineering George Wald going groups hazards hearings human industry insulin interest involved issue knowledge laboratory legislation licensing Lilly ment microorganisms molecular molecular biology molecule research National nature NIH guidelines nuclear organisms patent pathogenic PIECZENIK plasmid political possible potential present problem procedures production protection protein question recombinant DNA molecules recombinant DNA research recombinant DNA technology regulation require responsibility risk risk-benefit risk-benefit analysis safety scientific community scientists Secretary Sinsheimer social society specific statement strains Subcommittee suggested testimony Thank things tion tRNA University viruses